Screening for Cognitive Dysfunctions in Patients with Combined Hashish and Tramadol Addiction
Keywords:
screening, MOSA test, cognitive dysfunction, poly addiction, combined addiction, hashish, tramadol
Abstract
Relevance: A predictor of determining the quality of treatment is the patient's cognitive abilities, which can be a useful screening tool for alerting potential problems during treatment. Purpose: screening of cognitive functions in patients with combined addiction to hashish and tramadol. Materials and methods: 129 male patients divided into 3 groups: group 1 (main) -41% of patients (n=53) with combined abuse of hashish and tramadol. Group 2 (control) - 34% of patients (n=44) with tramadol dependence. Group 3 (control) - 24.8% of patients (n=32) with dependence on cannabinoids. The level of reliability P lt;0.05 was taken as statistically significant changes. Results: The average score on the MOCA scale was 21.3#xB1;0.79 in patients of group 1, in group 2, 24.52#xB1;0.92 (P1-2 lt;0.01), in group 3, 22.8#xB1;0.8 (P1 -3gt; 0.05). Patients with poly addiction and hashish dependence have violations of all medical processes - fixation, retention, and reproduction. Combined abuse of hashish and tramadol results in a synergy between the two psychoactive substances, which negatively affects cognitive functioning. Conclusion: The cannabinoid group is a major source of cognitive dysfunction. The MOSA test allows screening to the study of cognitive dysfunctions in general, regardless of individual cognitive domains, and to select the tactics of personalized drug and psychotherapeutic therapy.
Downloads
- Article PDF
- TEI XML Kaleidoscope (download in zip)* (Beta by AI)
- Lens* NISO JATS XML (Beta by AI)
- HTML Kaleidoscope* (Beta by AI)
- DBK XML Kaleidoscope (download in zip)* (Beta by AI)
- LaTeX pdf Kaleidoscope* (Beta by AI)
- EPUB Kaleidoscope* (Beta by AI)
- MD Kaleidoscope* (Beta by AI)
- FO Kaleidoscope* (Beta by AI)
- BIB Kaleidoscope* (Beta by AI)
- LaTeX Kaleidoscope* (Beta by AI)
How to Cite
Published
2020-10-15
Issue
Section
License
Copyright (c) 2020 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.